Lance Grady leads the Market Access Practice.
He devises commercialization strategies focused on value, access, and reimbursement. With a focus on oncology and over 20 years of experience in policy, access, reimbursement strategy and execution, and point-of-care, he is passionate about providing practical and meaningful solutions that are viable to all healthcare stakeholders. Lance delivers proven, measurable outcomes by creating integrative and sustainable solutions in functional areas pertaining to: patient access strategy and services; physician-administered reimbursement strategy and support; value-based and risk-based payment models; CMS policy strategy; Medicare payment models; commercial health plan formulary, medical policy, and utilization management; benefit design; drug-dollar-data flow; oncology pathways; specialty channel strategies—pharmacy, GPO, and wholesaler distribution.
Prior, Lance enjoyed a successful 12-year career at Bristol-Myers Squibb in various leadership roles in U.S. Market Access. He also has experience in orphan drug and autoimmune therapeutic markets.
He is a graduate of the University of Louisiana-Monroe where he studied human biology and immunobiology.